Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.
D000700:Analgesics / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000983:Antipyrine / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D006168:Guinea Pigs; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D007674:Kidney Diseases / Q000139:chemically induced*; D007677:Kidney Function Tests; D007681:Kidney Papillary Necrosis / Q000139:chemically induced; D051379:Mice; D010615:Phenacetin / Q000009:adverse effects*; D011817:Rabbits; D051381:Rats; D012459:Salicylates / Q000009:adverse effects / Q000627:therapeutic use; D019966:Substance-Related Disorders
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D012459:Salicylates; D010615:Phenacetin; D000983:Antipyrine